These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
455 related articles for article (PubMed ID: 27265220)
1. Outcome of Gleason 3 + 5 = 8 Prostate Cancer Diagnosed on Needle Biopsy: Prognostic Comparison with Gleason 4 + 4 = 8. Harding-Jackson N; Kryvenko ON; Whittington EE; Eastwood DC; Tjionas GA; Jorda M; Iczkowski KA J Urol; 2016 Oct; 196(4):1076-81. PubMed ID: 27265220 [TBL] [Abstract][Full Text] [Related]
2. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Epstein JI; Amin MB; Reuter VE; Humphrey PA Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964 [TBL] [Abstract][Full Text] [Related]
3. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System. Epstein JI; Egevad L; Amin MB; Delahunt B; Srigley JR; Humphrey PA; Am J Surg Pathol; 2016 Feb; 40(2):244-52. PubMed ID: 26492179 [TBL] [Abstract][Full Text] [Related]
4. The impact of the 2005 International Society of Urological Pathology consensus guidelines on Gleason grading - a matched-pair analysis. Berg KD; Thomsen FB; Nerstrøm C; Røder MA; Iversen P; Toft BG; Vainer B; Brasso K BJU Int; 2016 Jun; 117(6):883-9. PubMed ID: 26823232 [TBL] [Abstract][Full Text] [Related]
5. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System. Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985 [TBL] [Abstract][Full Text] [Related]
6. Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue. Gottipati S; Warncke J; Vollmer R; Humphrey PA Am J Surg Pathol; 2012 Jun; 36(6):900-7. PubMed ID: 22367295 [TBL] [Abstract][Full Text] [Related]
7. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens. Kır G; Seneldir H; Gumus E Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655 [TBL] [Abstract][Full Text] [Related]
8. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. Pierorazio PM; Walsh PC; Partin AW; Epstein JI BJU Int; 2013 May; 111(5):753-60. PubMed ID: 23464824 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer. Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670 [TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the prostate with Gleason score 9-10 on core biopsy: correlation with findings at radical prostatectomy and prognosis. Ellis CL; Partin AW; Han M; Epstein JI J Urol; 2013 Dec; 190(6):2068-73. PubMed ID: 23727307 [TBL] [Abstract][Full Text] [Related]
12. Characteristics and outcome of prostate cancer patients with overall biopsy Gleason score 3 + 4 = 7 and highest Gleason score 3 + 4 = 7 or > 3 + 4 = 7. Verhoef EI; Kweldam CF; Kümmerlin IP; Nieboer D; Bangma CH; Incrocci L; van der Kwast TH; Roobol MJ; van Leenders GJ Histopathology; 2018 Apr; 72(5):760-765. PubMed ID: 29094386 [TBL] [Abstract][Full Text] [Related]
13. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy. Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236 [TBL] [Abstract][Full Text] [Related]
14. Comparison of Classic and International Society of Urological Pathology 2005 Modified Gleason grading using needle biopsies from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) trial. Lucia MS; Bostwick DG; Somerville MC; Fowler IL; Rittmaster RS Arch Pathol Lab Med; 2013 Dec; 137(12):1740-6. PubMed ID: 24283854 [TBL] [Abstract][Full Text] [Related]
15. Gleason score 3 + 4=7 prostate cancer with minimal quantity of gleason pattern 4 on needle biopsy is associated with low-risk tumor in radical prostatectomy specimen. Huang CC; Kong MX; Zhou M; Rosenkrantz AB; Taneja SS; Melamed J; Deng FM Am J Surg Pathol; 2014 Aug; 38(8):1096-101. PubMed ID: 24832163 [TBL] [Abstract][Full Text] [Related]
16. PSA failure following definitive treatment of prostate cancer having biopsy Gleason score 7 with tertiary grade 5. Patel AA; Chen MH; Renshaw AA; D'Amico AV JAMA; 2007 Oct; 298(13):1533-8. PubMed ID: 17911498 [TBL] [Abstract][Full Text] [Related]
17. ISUP Group 4 - a Homogenous Group of Prostate Cancers? Lu TC; Moretti K; Beckmann K; Cohen P; O'Callaghan M Pathol Oncol Res; 2018 Oct; 24(4):921-925. PubMed ID: 29079965 [TBL] [Abstract][Full Text] [Related]
18. Prognostic importance of Gleason 7 disease among patients treated with external beam radiation therapy for prostate cancer: results of a detailed biopsy core analysis. Spratt DE; Zumsteg Z; Ghadjar P; Pangasa M; Pei X; Fine SW; Yamada Y; Kollmeier M; Zelefsky MJ Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1254-61. PubMed ID: 23182392 [TBL] [Abstract][Full Text] [Related]
19. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up. Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244 [TBL] [Abstract][Full Text] [Related]
20. Gleason score 7 prostate cancer on needle biopsy: relation of primary pattern 3 or 4 to pathological stage and progression after radical prostatectomy. Amin A; Partin A; Epstein JI J Urol; 2011 Oct; 186(4):1286-90. PubMed ID: 21862072 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]